Pharma stocks defy market trend: Dr Reddy’s, Aurobindo, Granules among top gainers as investors turn to defensive bets amid global developments (Image: Canva) Pharma stocks are bucking the ...

The German pharmaceutical and agricultural company said Tuesday that it expects to be able to manage the impact of tariffs and doesn’t see a need to revise its guidance. A strong pharma ...

In the wake of the horrific attack on unarmed civilians in Pahalgam in April, New Delhi made the momentous decision to suspend the Indus Waters Treaty (IWT). It was an unprecedented move in the ...

The Pharma stocks are seeing big cuts in early trade. The Nifty Pharma Index is down over 1% and the BSE Healthcare Index too remains under pressure. Some of the big Nifty losers include the likes ...

New Delhi: With Vodafone Idea clearing its large overdues to Indus Towers, the tower company said it plans to aggressively expand its market share using both organic and acquisition means.

The pharma industry’s reputation has continued to slide — and it’s mostly due to the persistent issue of high drug costs, according to a report released by research firm PatientView this week.

Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure ...

India is building two water storage facilities which would help store Indus water now that the Water sharing treaty with Pakistan has been put on hold indefinitely, AK Bajaj, Former Commissioner ...

“The trading window shall be deemed to be closed in respect of the aforementioned purposes as well, in accordance with applicable laws,” said Indus Towers in its filing. The Indus Towers stock—traded ...

Following a terrorist attack in Pahalgam, India has suspended the Indus Waters Treaty with Pakistan, halting data sharing and potentially allowing for increased water usage from the western rivers.

Former Central Water Commission head Kushvinder Vohra said India can leverage the stalled Indus Waters Treaty to impact Pakistan, and is no longer obligated to share water data. India may also ...

LONDON, April 25 (Reuters) - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on ...